ABVXAbivax - ADR

Abivax said underwriters have fully exercised their option to purchase an additional 960,000 American depositary shares as part of their $920 million offering.

The size of the offering was increased to $800 million from the previously announced offering of $600 million in ADSs.

(RTTNews) - Wednesday, ABIVAX Soci?t? Anonyme (ABVX) announced the pricing of an underwritten public offering of 6.4 million American Depositary Shares or ADSs, each representing one ordinary share, 0.01 nominal value per share, of the company, for $125 per ADS...

Wedbush, BTIG and Jefferies weighed in on ABVX on Tuesday after the company unveiled updated safety and efficacy data from an obefazimod study.

Stocks up, Dow Jones +100 points. AEVEX Corp shares rose 11.8% on $50m Air Force contract. Other big gainers: ABVX +34.2%, ESBA +20.9%, AVAV +20.4%, AIRJ +17.4%, FCEL +14%, UMAC +11.1%, HSAI +10.7%, PROK +9.3%, WOLF +9.1%, APD +8.6%read more...

Abivax (ABVX) stock skyrockets 36% following strong Phase 3 maintenance data for its ulcerative colitis treatment. Get the latest details.read more...

Stock Futures Flat As S&P Closes Out Best Quarter In 6 Years US index futures erased an earlier gain following some belligerent Iran headlines, but are still set to end?a quarter that is set to be the S&P 500's best in six years with markets behaving as though period-end dynamics have...

Gainers Abivax (NASDAQ:ABVX) shares increased by 36.0% to $130.74 during Tuesday's pre-market session. The company's market cap stands at $7.6 billion. Cuprina Holdings (Cayman) (NASDAQ:CUPR) shares movedread more...

Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease...